| PERIOD ENDING | 30-Jun-09 | 30-Jun-08 |
| Total Revenue |
-
|
-
|
| Cost of Revenue |
-
|
-
|
|
| Gross Profit |
-
|
-
|
|
| Operating Expenses |
| Research Development |
-
|
-
|
| Selling General and Administrative | 436 | 356 |
| Non Recurring |
-
|
-
|
| Others |
-
|
-
|
| |
| Total Operating Expenses |
-
|
-
|
|
|
| Operating Income or Loss | (436) | (356) |
|
| Income from Continuing Operations |
| Total Other Income/Expenses Net |
-
|
-
|
| Earnings Before Interest And Taxes | (436) | (356) |
| Interest Expense | 15 | 16 |
| Income Before Tax | (451) | (372) |
| Income Tax Expense |
-
|
-
|
| Minority Interest |
-
|
-
|
| |
| Net Income From Continuing Ops | (451) | (372) |
|
| Non-recurring Events |
| Discontinued Operations |
-
|
-
|
| Extraordinary Items |
-
|
-
|
| Effect Of Accounting Changes |
-
|
-
|
| Other Items |
-
|
-
|
|
|
| Net Income | (451) | (372) |
| Preferred Stock And Other Adjustments |
-
|
-
|
|
| Net Income Applicable To Common Shares | ($451) | ($372) |
0.10% Nasdaq 
0.27%
Income Statement
